TY - JOUR
T1 - Parkin ubiquitinates Drp1 for proteasome-dependent degradation
T2 - Implication of dysregulated mitochondrial dynamics in Parkinson disease
AU - Wang, Hongxia
AU - Song, Pingping
AU - Du, Lei
AU - Tian, Weili
AU - Yue, Wen
AU - Liu, Min
AU - Li, Dengwen
AU - Wang, Bin
AU - Zhu, Yushan
AU - Cao, Cheng
AU - Zhou, Jun
AU - Chen, Quan
PY - 2011/4/1
Y1 - 2011/4/1
N2 - Mutations in Parkin, an E3 ubiquitin ligase that regulates protein turnover, represent one of the major causes of familial Parkinson disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons and impaired mitochondrial functions. The underlying mechanism by which pathogenic Parkin mutations induce mitochondrial abnormality is not fully understood. Here, we demonstrate that Parkin interacts with and subsequently ubiquitinates dynamin-related protein 1 (Drp1), for promoting its proteasome-dependent degradation. Pathogenic mutation or knockdown of Parkin inhibits the ubiquitination and degradation of Drp1, leading to an increased level of Drp1 for mitochondrial fragmentation. These results identify Drp1 as a novel substrate of Parkin and suggest a potential mechanism linking abnormal Parkin expression to mitochondrial dysfunction in the pathogenesis of Parkinson disease.
AB - Mutations in Parkin, an E3 ubiquitin ligase that regulates protein turnover, represent one of the major causes of familial Parkinson disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons and impaired mitochondrial functions. The underlying mechanism by which pathogenic Parkin mutations induce mitochondrial abnormality is not fully understood. Here, we demonstrate that Parkin interacts with and subsequently ubiquitinates dynamin-related protein 1 (Drp1), for promoting its proteasome-dependent degradation. Pathogenic mutation or knockdown of Parkin inhibits the ubiquitination and degradation of Drp1, leading to an increased level of Drp1 for mitochondrial fragmentation. These results identify Drp1 as a novel substrate of Parkin and suggest a potential mechanism linking abnormal Parkin expression to mitochondrial dysfunction in the pathogenesis of Parkinson disease.
UR - http://www.scopus.com/inward/record.url?scp=79953231682&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953231682&partnerID=8YFLogxK
U2 - 10.1074/jbc.M110.144238
DO - 10.1074/jbc.M110.144238
M3 - Article
C2 - 21292769
AN - SCOPUS:79953231682
SN - 0021-9258
VL - 286
SP - 11649
EP - 11658
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 13
ER -